Converging evidence for frontopolar cortex as a target for neuromodulation in addiction treatment / Ghazaleh Soleimani en The American Journal of Psychiatry, Año 2024 - Vol. 181 - No. 2 (Febrero)

Público ISBD [artículo]  inThe American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 2 (Febrero) . - pp. 100-114 Título : Converging evidence for frontopolar cortex as a target for neuromodulation in addiction treatment Tipo de documento: texto impreso Autores: Ghazaleh Soleimani, Autor ; Juho Joutsa, Autor ; Khaled Moussawi, Autor Fecha de publicación: 2024 Artículo en la página: pp. 100-114 Idioma : Inglés (eng) Idioma original : Inglés (eng) Palabras clave: Marcadores biológicos, Psiquiatría de adicciones, Neuroimagen, Neuroestimulación, TMS, Trastornos adictivos y relacionados con sustancias Resumen: Noninvasive brain stimulation technologies such as transcranial electrical and magnetic stimulation (tES and TMS) are emerging neuromodulation therapies that are being used to target the neural substrates of substance use disorders. By the end of 2022, 205 trials of tES or TMS in the treatment of substance use disorders had been published, with heterogeneous results, and there is still no consensus on the optimal target brain region. Link: ./index.php?lvl=notice_display&id=31343 [artículo] Converging evidence for frontopolar cortex as a target for neuromodulation in addiction treatment [texto impreso] / Ghazaleh Soleimani, Autor ; Juho Joutsa, Autor ; Khaled Moussawi, Autor . - 2024 . - pp. 100-114. Idioma : Inglés (eng) Idioma original : Inglés (eng) in The American Journal of Psychiatry > Año 2024 - Vol. 181 - No. 2 (Febrero) . - pp. 100-114 Palabras clave: Marcadores biológicos, Psiquiatría de adicciones, Neuroimagen, Neuroestimulación, TMS, Trastornos adictivos y relacionados con sustancias Resumen: Noninvasive brain stimulation technologies such as transcranial electrical and magnetic stimulation (tES and TMS) are emerging neuromodulation therapies that are being used to target the neural substrates of substance use disorders. By the end of 2022, 205 trials of tES or TMS in the treatment of substance use disorders had been published, with heterogeneous results, and there is still no consensus on the optimal target brain region. Link: ./index.php?lvl=notice_display&id=31343

---

1 (1 - 1 / 1)